Search results

Guidance on using the Rapid Cancer Registration Data (RCRD) to measure progress against the 75% staging ambition.

The National Disease Registration Service (NDRS) undertakes analysis to understand the impact of comorbidities on cancer patients.

This article explains the methodologies applied when using the SACT data set to evaluate CDF treatments.

The British Association of Dermatologists (BAD) and the National Disease Registry Service (NDRS) partnership is a collaborative and multidisciplinary team with clinical, epidemiological, and analytical expertise. Using the high-quality national skin cancer data, the partnership aims to support patient...

Artificial data sets provide users with large volumes of data that share some of the characteristics of real data while protecting patient confidentiality. They are designed to model the structure of real data but are completely artificial – they do not contain any actual patient records.

This document provides guidance to clinicians reporting regimen outcomes for non-curative treatments in the systemic anti-cancer therapy (SACT) data set.